Dr. Kira Rubtsova is a senior research scientist in Immunology Discovery, at Eli Lilly and Company, San Diego. She earned her PhD at University of Colorado in laboratory of Dr. John Kappler studying TCR-MHC interactions. She did her post doc training at National Jewish Health Center in laboratory of Dr. Pippa Marrack, where she studied B cells in the context of autoimmunity working on novel subset of B cells – Age-Associated B cells, ABCs, and their role in the development of autoimmunity. At Eli Lilly Dr. Rubtsova is a project leader of large, cross-functional team developing large molecule therapeutics for treatment of autoimmune diseases. | Kira Rubtsova, PhD. |. Senior Research Scientist, Discovery, Immunology, Eli Lilly and Company